Patents by Inventor Daniel P. Cafaro

Daniel P. Cafaro has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6024954
    Abstract: Compositions for disinfecting contact lenses include a liquid medium containing a chlorite component, preferably a water soluble chlorite component, in a contact lens disinfecting amount, and a polyanionic component, preferably a water soluble polyanionic component, in an amount effective to do at least one of the following: inhibit formation of protein deposit material on a contact lens immersed in the composition; reduce the toxicity of the composition to the human eye, and reduce the damage to a contact lens caused by immersing the contact lens in the composition. The composition has a viscosity of less than 50 cps at 25.degree. C., an osmolality of at least about 200 mOsmol/kg, and preferably a pH in the range of about 6 to about 9.
    Type: Grant
    Filed: August 2, 1996
    Date of Patent: February 15, 2000
    Assignee: Allergan
    Inventors: John Y. Park, Lin Peng, Daniel P. Cafaro, Anthony J. Dziabo
  • Patent number: 5746972
    Abstract: Compositions and methods for disinfecting and cleaning contact lenses include a liquid medium containing hydrogen peroxide and a defined ethylene oxide/propylene oxide block copolymer. An advantageously reduced amount of foaming occurs when the hydrogen peroxide is destroyed, particularly by the action of catalase.
    Type: Grant
    Filed: November 1, 1996
    Date of Patent: May 5, 1998
    Assignee: Allergan
    Inventors: John Y. Park, Larry K. Thomas, Lin Peng, Daniel P. Cafaro
  • Patent number: 5589387
    Abstract: A method for using a composition including a neutralizing system and a sequestering agent which prevents the accumulation of inorganic deposits on contact lenses, particularly when used regularly in a conventional hydrogen peroxide disinfection regimen. The neutralizing system includes at least one reducing agent, a reductase, or both. The sequestering agent preferably is gluconic acid, a polymetaphosphate or their salts. Sodium hexametaphosphate is the most preferred sequestering agent; catalase is the most preferred agent for use as the neutralizing system.
    Type: Grant
    Filed: June 6, 1995
    Date of Patent: December 31, 1996
    Assignee: Allergan, Inc.
    Inventor: Daniel P. Cafaro
  • Patent number: 5447650
    Abstract: A composition including a neutralizing system and a sequestering agent is described which prevents the accumulation of inorganic deposits on contact lenses, particularly when used regularly in a conventional hydrogen peroxide disinfection regimen. The neutralizing system includes at least one reducing agent, a reductase, or both. The sequestering agent preferably is gluconic acid, a polymetaphosphate or their salts. Sodium hexametaphosphate is the most preferred sequestering agent; catalase is the most preferred agent for use as the neutralizing system.
    Type: Grant
    Filed: October 6, 1993
    Date of Patent: September 5, 1995
    Assignee: Allergan, Inc.
    Inventor: Daniel P. Cafaro